ULK1 and neoplasm: Collectively, these data from two independent in vivo models indicate that tissue-specific Ulk1 depletion enhances antitumor immune responses by markedly reducing immunosuppressive neutrophils and PMN-MDSCs, promoting APCs and substantially increasing CD8+ T cell infiltration, thereby contributing to tumor regression.